Literature DB >> 6489639

Biological properties and dog response to a variant (M-) strain of Brucella canis.

L E Carmichael, S J Zoha, R Flores-Castro.   

Abstract

Wild type (virulent) B. canis organisms are always rough and growth becomes extremely mucoid (M+) after several days of incubation, especially on media pH 7.2. The mucoid growth of virulent (M+) B. canis and the marked tendency for M+ bacteria, and extracted cell wall antigens, to aggregate at acid pH (pH less than 6.5) are markedly diminished in a less mucoid (M-) variant. The M+ and M- Brucella, and their extracted cell wall antigens, also differ in hydrophobic properties; the M+ organisms (and antigens) being the more hydrophobic. Immunoelectrophoresis and immunodiffusion analysis also revealed differences between the two strains. Prolonged survival (greater than 1 year) of B. canis in host tissues, with the production of abortions or epididymitis/orchitis is a principal expression of B. canis virulence. Pathogenicity studies in Beagles have indicated that the M- variant is reduced in virulence, since dogs given high doses of the M- strain by the subcutaneous or conjunctival/oral routes remained asymptomatic. Abortions did not occur in experimentally infected pregnant bitches and there was no epididymitis/orchitis in inoculated males. Nevertheless, M- bacteria persisted in the spleen, prostate tissue of some males, and in the lymph nodes for 3 to 9 postinoculation months. Serological responses of dogs to the M-organisms were generally weaker and less enduring than in dogs infected with the M+ Brucella. Sera from dogs infected with the M- strain generally reacted weakly in agglutination tests, especially when the antigen was B. ovis. The minimum infectious dose of M + B. canis was at least five times less than that of the M - Brucella (conjunctival or subcutaneous routes).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6489639

Source DB:  PubMed          Journal:  Dev Biol Stand        ISSN: 0301-5149


  3 in total

1.  Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.

Authors:  Maria Clausse; Alejandra G Díaz; Andrés E Ibañez; Juliana Cassataro; Guillermo H Giambartolomei; Silvia M Estein
Journal:  Clin Vaccine Immunol       Date:  2014-10-22

2.  The first case of Brucella canis in Sweden: background, case report and recommendations from a northern European perspective.

Authors:  Bodil Ström Holst; Karin Löfqvist; Linda Ernholm; Karin Eld; Maria Cedersmyg; Gunilla Hallgren
Journal:  Acta Vet Scand       Date:  2012-03-27       Impact factor: 1.695

3.  Human infection with M- strain of Brucella canis.

Authors:  Jorge C Wallach; Guillermo H Giambartolomei; Pablo C Baldi; Carlos A Fossati
Journal:  Emerg Infect Dis       Date:  2004-01       Impact factor: 6.883

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.